[
    [
        {
            "time": "2020-06-29",
            "original_text": "复星医药（02196）：RT002用于颈部肌张力障碍治疗获国家药监局临床试验注册审评受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "RT002",
                    "颈部肌张力障碍",
                    "临床试验",
                    "国家药监局"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药（02196）：RT002用于颈部肌张力障碍治疗获国家药监局临床试验注册审评受理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "投资人视角丨国家联采办“拍了拍”各大药企，第三批药品集采工作蓄势待发！",
            "features": {
                "keywords": [
                    "国家联采办",
                    "药品集采",
                    "第三批",
                    "药企"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "投资人视角丨国家联采办“拍了拍”各大药企，第三批药品集采工作蓄势待发！",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "复星医药（600196.SH）：复星医药产业药品临床试验申请获受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "临床试验",
                    "药品",
                    "申请受理"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药（600196.SH）：复星医药产业药品临床试验申请获受理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "新冠疫苗研发传捷报，概念股大涨，康华生物涨停丨牛熊眼",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "研发",
                    "捷报",
                    "概念股",
                    "康华生物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠疫苗研发传捷报，概念股大涨，康华生物涨停丨牛熊眼",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "华创事件驱动早报6-29：新冠疫苗研发再传捷报；商业银行有望获得券商牌照",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "研发",
                    "捷报",
                    "商业银行",
                    "券商牌照"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华创事件驱动早报6-29：新冠疫苗研发再传捷报；商业银行有望获得券商牌照",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]